Planet Briefing

First published · Last updated

Disrupting aberrant EGFR catalytic trimers reverses T790M gefitinib resistance

A preprint posted to openRxiv on 2026-09-25 reports that disrupting EGFR catalytic trimers can reverse T790M-associated gefitinib resistance. The source provided is a posted content entry with no additional methodological or outcome details in the supplied record.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
5/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
6/10
Urgency
2/10

Why it matters

The report describes a potential approach to overcome a form of drug resistance in EGFR-mutant cancers.

Sources

Report an issue